The oncofetal IGF2 mRNA-binding protein 1 (IGF2BP1) is a crucial regulator of tumor and stem cell fate and its elevated expression in a multitude of tumors is associated with poor prognosis (Degrauwe et al., 2016; Hattori et al., 2016). Here, IGF2BP1 is linked to neoplasm.